<DOC>
	<DOCNO>NCT00241722</DOCNO>
	<brief_summary>Adults take opioid therapy persistent non-cancer pain result opioid-induced bowel dysfunction ( OBD ) randomize ( 1:1 ) alvimopan placebo . The primary objective Phase 3 long-term safety study compare alvimopan placebo safety tolerability treatment OBD . Participants require attend 8 clinic visit approximately 1 year .</brief_summary>
	<brief_title>Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Alvimopan</mesh_term>
	<criteria>Inclusion criterion : Consented participate study . Taking opioid therapy persistent noncancer pain . Has bowel dysfunction mainly due opioids . Has bowel dysfunction since start opioids define infrequent bowel movement additional bowelrelated symptom . Willing discontinue laxative therapy ( provide studyspecific standardize laxative need ) . Exclusion criterion : Pregnant , lactating , plan become pregnant . Not ambulatory . Participated another trial investigational drug past 30 day . Taking opioids management drug addiction cancerrelated pain . Severe constipation whereby subject immediate risk develop serious complication constipation . Gastrointestinal pelvic disorder know affect bowel transit , produce gastrointestinal ( GI ) obstruction , contribute bowel dysfunction . Human Immunodeficiency Virus ( HIV ) infect , active hepatitis , ever infect hepatitis C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>bowel dysfunction</keyword>
	<keyword>constipation</keyword>
	<keyword>gastrointestinal</keyword>
	<keyword>opioids</keyword>
	<keyword>pain</keyword>
	<keyword>non-cancer pain</keyword>
	<keyword>opioid-induced</keyword>
</DOC>